New Predictive Model Enables Better Diagnosis of Fibromyalgia, Study Suggests

New Predictive Model Enables Better Diagnosis of Fibromyalgia, Study Suggests
A new model may help diagnose fibromyalgia earlier and improve treatment, a study by ProCare Pain Solutions and Pfizer suggests. The research, “Clinical Characteristics of Fibromyalgia in a Chronic Pain Population,” was published in the journal Pain Practice. It is the first in a series of three articles sponsored by Pfizer. Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, joint stiffness, and fatigue. Clinical diagnosis and classification of its severity rely on the American College of Rheumatology (ACR) 2010 criteria, which includes the Widespread Pain Index (WPI) and the Symptom Severity Index (SSI). However, most community-based physicians do not routinely use the establish
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *